HCPCS REQUIRING CORRESPONDING NDC CODES

Size: px
Start display at page:

Download "HCPCS REQUIRING CORRESPONDING NDC CODES"

Transcription

1 HCPCS REQUIRING CORRESPONDING NDC CODES A list of the HCPCS which will require a corresponding NDC can be found on the FHSC Website at If you are unable to access the FHSC Website, please contact FHSC s Provider Inquiry Unit at (907) or (800) (toll-free in Alaska) to request a hard copy. The list of procedure codes affected by the J Code NDC Requirements is now available on the FHSC Website listed above! Please use this list when determining which codes require a NDC code in order to be considered for reimbursement. The Deficit Reduction Act requires State Medicaid programs to collect rebates for physician and outpatient facility administered drugs. To facilitate this mandate, beginning April 1, 2008, drugs administered in a clinical setting which are billed with a HCPCS code or a revenue code 025x or 063x must include the corresponding NDC number, unit of measurement, and numeric quantity. Beginning April 1, 2008, payment for physician administered drugs will be based on the NDC and NDC quantity not on the HCPCS codes and units. Providers may bill for administration of the drug using the appropriate CPT code. For rebateable drugs, Medicaid will pay for the drug only if the manufacturer is participating in the Federal Drug Rebate Program. The CMS website provides a complete list of rebateable drugs. Claims submitted for drugs from manufacturers that are not part of the drug rebate program on the claim date of services will be denied.

2

3 Proc Code Description J0120 INJ TETRACYCLINE UP TO 250 MG J0128 INJ ABARELIX 10 MG J0129 INJ ABATACEPT 10 MG J0130 INJ ABCIXIMAB 10 MG J0132 INJ ACETYLCYSTEINE 100 MG J0133 INJ ACYCLOVIR 5 MG J0135 INJ ADALIMUMAB 20 MG J0150 INJ ADENOSINE FOR THERAPEUTIC USE 6 MG J0170 INJ ADRENALIN EPINEPHRINE UP TO 1 ML AMPULE J0180 INJ AGALSIDASE BETA 1 MG J0200 INJ ALATROFLOXACIN MESYLATE 100 MG J0205 INJ ALGLUCERASE PER 10 UNITS J0207 INJ AMIFOSTINE 500 MG J0210 INJ METHYLDOPATE HCL UP TO 250 MG J0215 INJ ALEFACEPT 0.5 MG J0220 INJ AGLUCOSIDASE ALFA 10 MG J0256 INJ ALPHA 1 - PROTEINASE INHIBITOR - HUMAN 10 MG J0278 INJ AMIKACIN SULFATE 100 MG J0280 INJ, AMINOPHYLLIN, UP TO 250 MG J0282 INJ AMIODARONE HCL 30 MG J0285 INJ AMPHOTERICIN B 50 MG J0287 INJ AMPHOTERICIN B LIPID COMPLEX 10 MG J0288 INJ AMPHOTERICIN B CHOLESTERYL SULFATE COMPLEX 10 MG J0289 INJ AMPHOTERICIN B LIPOSOME 10 MG J0290 INJ AMPICILLIN SODIUM 500 MG J0295 INJ AMPICILLIN SODIUM/SULBACTAM SODIUM PER 1.5 GM J0300 INJ AMOBARBITAL UP TO 125 MG J0330 INJ SUCCINYLCHOLINE CHLORIDE UP TO 20 MG J0348 INJ ANADULAFUNGIN 1 MG J0350 INJ ANISTREPLASE PER 30 UNITS J0360 INJ HYDRALAZINE HCL UP TO 20 MG J0364 INJ APOMORPHINE HCL 1 MG J0365 INJ APROTONIN KIU J0380 INJ METARAMINOL BITARTRATE PER 10 MG J0390 INJ CHLOROQUINE HCL UP TO 250 MG J0395 INJ ARBUTAMINE HCL 1 MG J0400 INJ ARIPIPRAZOLE IM 0.25 MG J0456 INJ AZITHROMYCIN 500 MG J0460 INJ ATROPINE SULFATE UP TO 0.3 MG J0470 INJ DIMERCAPROL PER 100 MG J0475 INJ BACLOFEN 10 MG J0476 INJ BACLOFEN 50 MCG FOR INTRATHECAL TRIAL J0480 INJ BASILIXIMAB 20 MG J0500 INJ DICYCLOMINE HCL UP TO 20 MG J0515 INJ BENZTROPINE MESYLATE PER 1 MG J0520 INJ BETHANECHOL CHLORIDE MYOTONACHOL OR URECHOLINE UP TO 5 MG J0530 INJ PENICILLIN G BENZATHINE AND PENICILLIN G PROCAINE UP TO 600 J0540 INJ PENICILLIN G BENZATHINE AND PENICILLIN G PROCAINE UP TO 1 20 J0550 INJ PENICILLIN G BENZATHINE AND PENICILLIN G PROCAINE UP TO 2 40 J0560 INJ PENICILLIN G BENZATHINE UP TO UNITS J0570 INJ PENICILLIN G BENZATHINE UP TO UNITS Page 1 of 12 February 8, 2008

4 J0580 J0583 J0585 J0587 J0592 J0594 J0595 J0600 J0610 J0620 J0630 J0636 J0637 J0640 J0670 J0690 J0692 J0694 J0696 J0697 J0698 J0702 J0704 J0706 J0710 J0713 J0715 J0720 J0725 J0735 J0740 J0743 J0744 J0745 J0760 J0770 J0780 J0795 J0800 J0835 J0850 J0878 J0881 J0882 J0885 J0886 J0894 J0895 J0900 J0945 J0970 J1000 INJ PENICILLIN G BENZATHINE UP TO UNITS INJ BIVALIRUDIN 1 MG BOTULINUM TOXIN TYPE A PER UNIT BOTULINUM TOXIN TYPE B PER 100 UNITS INJ BUPRENORPHINE HCL 0.1 MG INJ BUSULFAN 1 MG INJ BUTORPHANOL TARTRATE 1 MG INJ EDETATE CALCIUM DISODIUM UP TO 1000 MG INJ CALCIUM GLUCONATE PER 10 ML INJ CALCIUM GLYCEROPHOSPHATE AND CALCIUM LACTATE PER 10 ML INJ CALCITONIN SALMON UP TO 400 UNITS INJ CALCITRIOL 0.1 MCG INJ CASPOFUNGIN ACETATE 5 MG INJ LEUCOVORIN CALCIUM PER 50 MG INJ MEPIVACAINE HCL PER 10 ML INJ CEFAZOLIN SODIUM 500 MG INJ CEFEPIME HCL 500 MG INJ CEFOXITIN SODIUM 1 GM INJ CEFTRIAXONE SODIUM PER 250 MG INJ STERILE CEFUROXIME SODIUM PER 750 MG INJ CEFOTAXIME SODIUM PER GM INJ BETAMETHASONE ACETATE 3MG AND BETAMETHASONE SODIUM PHOSPHATE INJ BETAMETHASONE SODIUM PHOSPHATE PER 4 MG INJ CAFFEINE CITRATE 5MG INJ CEPHAPIRIN SODIUM UP TO 1 GM INJ CEFTAZIDIME PER 500 MG INJ CEFTIZOXIME SODIUM PER 500 MG INJ CHLORAMPHENICOL SODIUM SUCCINATE UP TO 1 GM INJ CHORIONIC GONADOTROPIN PER USP UNITS INJ CLONIDINE HCL 1 MG INJ CIDOFOVIR 375 MG INJ CILASTATIN SODIUM; IMIPENEM PER 250 MG INJ CIPROFLOXACIN FOR IV INFUSION 200 MG INJ CODEINE PHOSPHATE PER 30 MG INJ COLCHICINE PER 1MG INJ COLISTIMETHATE SODIUM UP TO 150 MG INJ PROCHLORPERAZINE UP TO 10 MG INJ CORTICORELIN OVINE TRIFLUTATE 1 MICROGRAM INJ CORTICOTROPIN UP TO 40 UNITS INJ COSYNTROPIN PER 0.25 MG INJ CYTOMEGALOVIRUS IMMUNE GLOBULIN IV (HUMAN) PER VIAL INJ DAPTOMYCIN 1 MG INJ DARBEPOETIN ALFA 1 MICROGRAM (NON-ESRD USE) INJ DARBEPOETIN ALFA 1 MICROGRAM (FOR ESRD ON DIALYSIS) INJ EPOETIN ALFA (FOR NON-ESRD USE) 1000 UNITS INJ EPOETIN ALFA 1000 UNITS (FOR ESRD ON DIALYSIS) INJ DECITABINE 1 MG INJ DEFEROXAMINE MESYLATE 500 MG INJ TESTOSTERONE ENANTHATE AND ESTRADIOL VALERATE UP TO 1 CC INJ BROMPHENIRAMINE MALEATE PER 10 MG INJ ESTRADIOL VALERATE UP TO 40 MG INJ DEPO-ESTRADIOL CYPIONATE UP TO 5 MG Page 2 of 12 February 8, 2008

5 J1020 J1030 J1040 J1051 J1055 J1056 J1060 J1070 J1080 J1094 J1100 J1110 J1120 J1160 J1162 J1165 J1170 J1180 J1190 J1200 J1205 J1230 J1240 J1245 J1260 J1265 J1270 J1300 J1320 J1324 J1325 J1327 J1330 J1335 J1364 J1380 J1390 J1410 J1430 J1435 J1436 J1438 J1440 J1441 J1450 J1451 J1452 J1455 J1457 J1458 J1460 J1470 INJ METHYLPREDNISOLONE ACETATE 20 MG INJ METHYLPREDNISOLONE ACETATE 40 MG INJ METHYLPREDNISOLONE ACETATE 80 MG INJ MEDROXYPROGESTERONE ACETATE 50 MG INJ MEDROXYPROGESTERONE ACETATE FOR CONTRACEPTIVE USE 150 MG INJ MEDROXYPROGESTERONE ACETATE / ESTRADIOL CYPIONATE 5MG / 25MG INJ TESTOSTERONE CYPIONATE AND ESTRADIOL CYPIONATE UP TO 1 ML INJ TESTOSTERONE CYPIONATE UP TO 100 MG INJ TESTOSTERONE CYPIONATE 1 CC 200 MG INJ DEXAMETHASONE ACETATE 1 MG INJ DEXAMETHASONE SODIUM PHOSPHATE 1MG INJ DIHYDROERGOTAMINE MESYLATE PER 1 MG INJ ACETAZOLAMIDE SODIUM UP TO 500 MG INJ DIGOXIN UP TO 0.5 MG INJ DIGOXIN IMMUNE FAB (OVINE) PER VIAL INJ PHENYTOIN SODIUM PER 50 MG INJ HYDROMORPHONE UP TO 4 MG INJ DYPHYLLINE UP TO 500 MG INJ DEXRAZOXANE HCL PER 250 MG INJ DIPHENHYDRAMINE HCL UP TO 50 MG INJ CHLOROTHIAZIDE SODIUM PER 500 MG INJ METHADONE HCL UP TO 10 MG INJ DIMENHYDRINATE UP TO 50 MG INJ DIPYRIDAMOLE PER 10 MG INJ DOLASETRON MESYLATE 10 MG INJ DOPAMINE HCL 40 MG INJ DOXERCALCIFEROL 1 MCG INJ ECULIZUMAB 10 MG INJ AMITRIPTYLINE HCL UP TO 20 MG INJ ENFUVIRTIDE 1 MG INJ EPOPROSTENOL 0.5 MG INJ EPTIFIBATIDE 5 MG INJ ERGONOVINE MALEATE UP TO 0.2 MG INJ ERTAPENEM SODIUM 500 MG INJ ERYTHROMYCIN LACTOBIONATE PER 500 MG INJ ESTRADIOL VALERATE UP TO 10 MG INJ ESTRADIOL VALERATE UP TO 20 MG INJ ESTROGEN CONJUGATED PER 25 MG INJ ETHANOLAMINE OLEATE 100 MG INJ ESTRONE PER 1 MG INJ ETIDRONATE DISODIUM PER 300 MG INJ ETANERCEPT 25 MG INJ FILGRASTIM (G-CSF) 300 MCG INJ FILGRASTIM (G-CSF) 480 MCG INJ FLUCONAZOLE 200 MG INJ FOMEPIZOLE 15 MG INJ FOMIVIRSEN SODIUM INTRAOCULAR 1.65 MG INJ FOSCARNET SODIUM PER 1000 MG INJ GALLIUM NITRATE 1 MG INJ GALSULFASE 1 MG INJ GAMMA GLOBULIN IM 1 CC INJ GAMMA GLOBULIN IM 2 CC Page 3 of 12 February 8, 2008

6 J1480 INJ GAMMA GLOBULIN IM 3 CC J1490 INJ GAMMA GLOBULIN IM 4 CC J1500 INJ GAMMA GLOBULIN IM 5 CC J1510 INJ GAMMA GLOBULIN IM 6 CC J1520 INJ GAMMA GLOBULIN IM 7 CC J1530 INJ GAMMA GLOBULIN IM 8 CC J1540 INJ GAMMA GLOBULIN IM 9 CC J1550 INJ GAMMA GLOBULIN IM 10 CC J1560 INJ GAMMA GLOBULIN IM OVER 10 CC J1561 INJ, IMMUNE GLOBULIN,(GAMUNEX) IV J1562 INJ IMMUNE GLOBULIN (VIVAGLOBIN) 100 MG J1565 INJ RESPIRATORY SYNCYTIAL VIRUS IMMUNE GLOBULIN IV 50 J1566 INJ IMMUNE GLOBULIN IV LYOPHILIZED (E.G. POWDER) NOT J1568 INJ IMMUNE GLOBULIN (OCTAGAM) IV NON-LYOPHILIZED (E.G J1569 INJ IMMUNE GLOBULIN (GAMMAGARD LIQUID) IV NON-LYOPHIL J1570 INJ GANCICLOVIR SODIUM 500 MG J1571 INJ HEPATITIS B IMMUNE GLOBULIN (HEPAGAM B) IM 0.5 M J1572 INJ IMMUNE GLOBULIN (FLEBOGAMMA) IV NON-LYOPHILIZED J1573 INJ HEPATITIS B IMMUNE GLOBULIN (HEPAGAM B) IV 0.5 ML J1580 INJ GARAMYCIN GENTAMICIN UP TO 80 MG J1595 INJ GLATIRAMER ACETATE 20 MG J1600 INJ GOLD SODIUM THIOMALATE UP TO 50 MG J1610 INJ GLUCAGON HCL PER 1 MG J1620 INJ GONADORELIN HCL PER 100 MCG J1625 INJ GRANISETRON HCL PER 1 MG J1626 INJ GRANISETRON HCL 100 MCG J1630 INJ HALOPERIDOL UP TO 5 MG J1631 INJ HALOPERIDOL DECANOATE PER 50 MG J1640 INJ HEMIN 1 MG J1642 INJ HEPARIN SODIUM (HEPARIN LOCK FLUSH) PER 10 UNITS J1644 INJ HEPARIN SODIUM PER 1000 UNITS J1645 INJ DALTEPARIN SODIUM PER 2500 IU J1650 INJ ENOXAPARIN SODIUM 10 MG J1652 INJ FONDAPARINUX SODIUM 0.5 MG J1655 INJ TINZAPARIN SODIUM 1000 IU J1670 INJ TETANUS IMMUNE GLOBULIN HUMAN UP TO 250 UNITS J1675 INJ HISTRELIN ACETATE 10 MICROGRAMS J1700 INJ HYDROCORTISONE ACETATE UP TO 25 MG J1710 INJ HYDROCORTISONE SODIUM PHOSPHATE UP TO 50 MG J1720 INJ HYDROCORTISONE SODIUM SUCCINATE UP TO 100 MG J1730 INJ DIAZOXIDE UP TO 300 MG J1740 INJ IBANDRONATE SODIUM 1 MG J1742 INJ IBUTILIDE FUMARATE 1 MG J1743 INJ IDURSULFASE 1 MG J1745 INJ INFLIXIMAB 10 MG J1751 INJ, IRON DEXTRAN 165, 50 MG J1752 INJ, IRON DEXTRAN 267, 50 MG J1756 INJ, IRON SUCROSE, 1 MG J1785 INJ IMIGLUCERASE PER UNIT J1790 INJ DROPERIDOL UP TO 5 MG J1800 INJ PROPRANOLOL HCL UP TO 1 MG J1810 INJ DROPERIDOL AND FENTANYL CITRATE UP TO 2 ML AMPULE Page 4 of 12 February 8, 2008

7 J1815 INJ INSULIN PER 5 UNITS J1825 INJ INTERFERON BETA-1A 33 MCG J1835 INJ ITRACONAZOLE 50 MG J1840 INJ KANAMYCIN SULFATE UP TO 500 MG J1850 INJ KANAMYCIN SULFATE UP TO 75 MG J1885 INJ KETOROLAC TROMETHAMINE PER 15 MG J1890 INJ CEPHALOTHIN SODIUM UP TO 1 GRAM J1931 INJ LARONIDASE 0.1 MG J1940 INJ FUROSEMIDE UP TO 20 MG J1945 INJ LEPIRUDIN 50 MG J1950 INJ LEUPROLIDE ACETATE (FOR DEPOT SUSPENSION) PER 3.75 MG J1955 INJ LEVOCARNITINE PER 1 GM J1956 INJ LEVOFLOXACIN 250 MG J1960 INJ LEVORPHANOL TARTRATE UP TO 2 MG J1980 INJ HYOSCYAMINE SULFATE UP TO 0.25 MG J1990 INJ CHLORDIAZEPOXIDE HCL UP TO 100 MG J2001 INJ LIDOCAINE HCL FOR IV INFUSION 10 MG J2010 INJ LINCOMYCIN HCL UP TO 300 MG J2020 INJ LINEZOLID 200MG J2060 INJ LORAZEPAM 2 MG J2150 INJ MANNITOL 25% IN 50 ML J2170 INJ MECASERMIN 1 MG J2175 INJ MEPERIDINE HCL PER 100 MG J2180 INJ MEPERIDINE AND PROMETHAZINE HCL UP TO 50 MG J2185 INJ MEROPENEM 100 MG J2210 INJ METHYLERGONOVINE MALEATE UP TO 0.2 MG J2248 INJ MICAFUNGIN SODIUM 1 MG J2250 INJ MIDAZOLAM HCL PER 1 MG J2260 INJ MILRINONE LACTATE 5 MG J2270 INJ MORPHINE SULFATE UP TO 10 MG J2271 INJ MORPHINE SULFATE 100MG J2275 INJ MORPHINE SULFATE (PRESERVATIVE-FREE STERILE SOLUTION) PER 10 J2278 INJ ZICONOTIDE 1 MICROGRAM J2280 INJ MOXIFLOXACIN 100 MG J2300 INJ NALBUPHINE HCL PER 10 MG J2310 INJ NALOXONE HCL PER 1 MG J2315 INJ NALTREXONE DEPOT FORM 1 MG J2320 INJ NANDROLONE DECANOATE UP TO 50 MG J2321 INJ NANDROLONE DECANOATE UP TO 100 MG J2322 INJ NANDROLONE DECANOATE UP TO 200 MG J2323 INJ NATALIZUMAB 1 MG J2325 INJ NESIRITIDE 0.1 MG J2353 INJ OCTREOTIDE DEPOT FORM FOR IM INJ 1 MG J2354 INJ OCTREOTIDE NON-DEPOT FORM FOR SUBQ OR IV J2355 INJ OPRELVEKIN 5 MG J2357 INJ OMALIZUMAB 5 MG J2360 INJ ORPHENADRINE CITRATE UP TO 60 MG J2370 INJ PHENYLEPHRINE HCL UP TO 1 ML J2400 INJ CHLOROPROCAINE HCL PER 30 ML J2405 INJ ONDANSETRON HCL PER 1 MG J2410 INJ OXYMORPHONE HCL UP TO 1 MG J2425 INJ PALIFERMIN 50 MICROGRAMS Page 5 of 12 February 8, 2008

8 J2430 INJ PAMIDRONATE DISODIUM PER 30 MG J2469 INJ PALONOSETRON HCL 25 MCG J2501 INJ PARICALCITOL 1 MCG J2503 INJ PEGAPTANIB SODIUM 0.3 MG J2504 INJ PEGADEMASE BOVINE 25 IU J2505 INJ PEGFILGRASTIM 6 MG J2510 INJ PENICILLIN G PROCAINE AQUEOUS UP TO UNITS J2513 INJ PENTASTARCH 10% SOLUTION 100 ML J2515 INJ PENTOBARBITAL SODIUM PER 50 MG J2540 INJ PENICILLIN G POTASSIUM UP TO UNITS J2543 INJ PIPERACILLIN SODIUM/TAZOBACTAM SODIUM 1 GRAM/0.125 GRAMS (1. J2545 PENTAMIDINE ISETHIONATE INH SOLUTION J2550 INJ PROMETHAZINE HCL UP TO 50 MG J2560 INJ PHENOBARBITAL SODIUM UP TO 120 MG J2590 INJ OXYTOCIN UP TO 10 UNITS J2597 INJ DESMOPRESSIN ACETATE PER 1 MCG J2650 INJ PREDNISOLONE ACETATE UP TO 1 ML J2670 INJ TOLAZOLINE HCL UP TO 25 MG J2675 INJ PROGESTERONE PER 50 MG J2680 INJ FLUPHENAZINE DECANOATE UP TO 25 MG J2690 INJ PROCAINAMIDE HCL UP TO 1 GM J2700 INJ OXACILLIN SODIUM UP TO 250 MG J2710 INJ NEOSTIGMINE METHYLSULFATE UP TO 0.5 MG J2720 INJ PROTAMINE SULFATE PER 10 MG J2724 INJ PROTEIN C CONCENTRATE IV HUMAN 10 IU J2725 INJ PROTIRELIN PER 250 MCG J2730 INJ PRALIDOXIME CHLORIDE UP TO 1 GM J2760 INJ PHENTOLAMINE MESYLATE UP TO 5 MG J2765 INJ METOCLOPRAMIDE HCL UP TO 10 MG J2770 INJ QUINUPRISTIN/DALFOPRISTIN 500 MG (150/350) J2778 INJ RANIBIZUMAB 0.1 MG J2780 INJ RANITIDINE HCL 25 MG J2783 INJ RASBURICASE 0.5 MG J2788 INJ RHO D IMMUNE GLOBULIN HUMAN MINIDOSE 50 MCG J2790 INJ RHO D IMMUNE GLOBULIN HUMAN FULL DOSE 300 MCG J2791 INJ RHO(D) IMMUNE GLOBULIN (HUMAN) (RHOPHYLAC) IM OR J2792 INJ RHO D IMMUNE GLOBULIN IV HUMAN SOLVENT DETERGENT J2794 INJ RISPERIDONE LONG ACTING 0.5 MG J2795 INJ ROPIVACAINE HCL 1 MG J2800 INJ METHOCARBAMOL UP TO 10 ML J2810 INJ THEOPHYLLINE PER 40 MG J2820 INJ SARGRAMOSTIM (GM-CSF) 50 MCG J2850 INJ SECRETIN SYNTHETIC HUMAN 1 MICROGRAM J2910 INJ AUROTHIOGLUCOSE UP TO 50 MG J2916 INJ SODIUM FERRIC GLUCONATE COMPLEX IN SUCROSE INJ 12.5 MG J2920 INJ METHYLPREDNISOLONE SODIUM SUCCINATE UP TO 40 MG J2930 INJ METHYLPREDNISOLONE SODIUM SUCCINATE UP TO 125 MG J2950 INJ PROMAZINE HCL UP TO 25 MG J2993 INJ RETEPLASE 18.1 MG J2995 INJ STREPTOKINASE PER IU J2997 INJ ALTEPLASE RECOMBINANT 1 MG J3000 INJ STREPTOMYCIN UP TO 1 GM Page 6 of 12 February 8, 2008

9 J3010 J3030 J3070 J3100 J3105 J3110 J3120 J3130 J3140 J3150 J3230 J3240 J3243 J3246 J3250 J3260 J3265 J3285 J3301 J3302 J3303 J3305 J3310 J3315 J3320 J3350 J3360 J3364 J3365 J3370 J3396 J3400 J3410 J3411 J3415 J3420 J3430 J3465 J3470 J3471 J3472 J3473 J3475 J3480 J3485 J3486 J3487 J3488 J3520 J3590 J7030 J7040 INJ FENTANYL CITRATE 0.1 MG INJ SUMATRIPTAN SUCCINATE 6 MG INJ PENTAZOCINE 30 MG INJ TENECTEPLASE 50MG INJ TERBUTALINE SULFATE UP TO 1 MG INJ TERIPARATIDE 10 MCG INJ TESTOSTERONE ENANTHATE UP TO 100 MG INJ TESTOSTERONE ENANTHATE UP TO 200 MG INJ TESTOSTERONE SUSPENSION UP TO 50 MG INJ TESTOSTERONE PROPIONATE UP TO 100 MG INJ CHLORPROMAZINE HCL UP TO 50 MG INJ THYROTROPIN ALPHA 0.9 MG PROVIDED IN 1.1 MG VIAL INJ TIGECYCLINE 1 MG INJ TIROFIBAN HCL 0.25MG INJ TRIMETHOBENZAMIDE HCL UP TO 200 MG INJ TOBRAMYCIN SULFATE UP TO 80 MG INJ TORSEMIDE 10 MG/ML INJ TREPROSTINIL 1 MG INJ TRIAMCINOLONE ACETONIDE PER 10MG INJ TRIAMCINOLONE DIACETATE PER 5MG INJ TRIAMCINOLONE HEXACETONIDE PER 5MG INJ TRIMETREXATE GLUCURONATE PER 25 MG INJ PERPHENAZINE UP TO 5 MG INJ TRIPTORELIN PAMOATE 3.75 MG INJ SPECTINOMYCIN DIHCL UP TO 2 GM INJ UREA UP TO 40 GM INJ DIAZEPAM UP TO 5 MG INJ UROKINASE 5000 IU VIAL INJ IV UROKINASE I.U. VIAL INJ VANCOMYCIN HCL 500 MG INJ VERTEPORFIN 0.1 MG INJ TRIFLUPROMAZINE HCL UP TO 20 MG INJ HYDROXYZINE HCL UP TO 25 MG INJ THIAMINE HCL 100 MG INJ PYRIDOXINE HCL 100 MG INJ VITAMIN B-12 CYANOCOBALAMIN UP TO 1000 MCG INJ PHYTONADIONE (VITAMIN K) PER 1 MG INJ VORICONAZOLE 10 MG INJ HYALURONIDASE UP TO 150 UNITS INJ HYALURONIDASE OVINE PRESERVATIVE FREE PER 1 USP UNIT (UP T INJ HYALURONIDASE OVINE PRESERVATIVE FREE PER 1000 USP UNITS INJ HYALURONIDASE RECOMBINANT 1 USP UNIT INJ MAGNESIUM SULFATE PER 500 MG INJ POTASSIUM CHLORIDE PER 2 MEQ INJ ZIDOVUDINE 10 MG INJ ZIPRASIDONE MESYLATE 10 MG INJ ZOLEDRONIC ACID (ZOMETA) 1 MG INJ ZOLEDRONIC ACID (RECLAST) 1 MG EDETATE DISODIUM PER 150 MG UNCLASSIFIED BIOLOGICS INFUSION NORMAL SALINE SOLUTION 1000 CC INFUSION NORMAL SALINE SOLUTION STERILE (500 ML=1 UNIT) Page 7 of 12 February 8, 2008

10 J7042 J7050 J7060 J7070 J7100 J7110 J7120 J7130 J7187 J7189 J7190 J7192 J7193 J7194 J7197 J7198 J7302 J7303 J7304 J7306 J7307 J7308 J7310 J7311 J7500 J7501 J7502 J7504 J7505 J7506 J7507 J7509 J7510 J7511 J7513 J7515 J7516 J7517 J7518 J7520 J7525 J7602 J7603 J7605 J7608 J7620 J7626 J7631 J7633 J7639 J7644 J7648 5% DEXTROSE/NORMAL SALINE (500 ML = 1 UNIT) INFUSION NORMAL SALINE SOLUTION 250 CC 5% DEXTROSE/WATER (500 ML = 1 UNIT) INFUSION D5W 1000 CC INFUSION DEXTRAN ML INFUSION, DEXTRAN 75, 500 ML RINGERS LACTATE INFUSION UP TO 1000 CC HYPERTONIC SALINE SOLUTION 50 OR 100 MEQ 20 CC VIAL INJ VON WILLEBRAND FACTOR COMPLEX (HUMATE-P) PER IU VWF:RCO FACTOR VIIA (ANTIHEMOPHILIC FACTOR RECOMBINANT) PER 1 MICROGRAM FACTOR VIII (ANTIHEMOPHILIC FACTOR HUMAN) PER I.U. FACTOR VIII (ANTIHEMOPHILIC FACTOR RECOMBINANT) PER I.U. FACTOR IX (ANTIHEMOPHILIC FACTOR PURIFIED NON-RECOMBINANT) PER I.U. FACTOR IX COMPLEX PER I.U. ANTITHROMBIN III (HUMAN) PER I.U. ANTI-INHIBITOR PER I.U. LEVONORGESTREL-RELEASING INTRAUTERINE CONTRACEPTIVE SYSTEM 52 MG CONTRACEPTIVE SUPPLY HORMONE CONTAINING VAGINAL RING EACH CONTRACEPTIVE SUPPLY HORMONE CONTAINING PATCH EACH LEVONORGESTREL (CONTRACEPTIVE) IMPLANT SYSTEM INCLUDING IMPLANTS AND SU ETONOGESTREL (CONTRACEPTIVE) IMPLANT SYSTEM INCLUDING IMPLANT AND SUPPL AMINOLEVULINIC ACID HCL FOR TOPICAL ADMINISTRATION 20% SINGLE UNIT DOS GANCICLOVIR 4.5 MG LONG-ACTING IMPLANT FLUOCINOLONE ACETONIDE INTRAVITREAL IMPLANT AZATHIOPRINE ORAL 50 MG AZATHIOPRINE PARENTERAL 100 MG CYCLOSPORINE, ORAL, 100 MG LYMPHOCYTE IMMUNE GLOBULIN ANTITHYMOCYTE GLOBULIN EQUINE PARENTERAL MUROMONAB-CD3 PARENTERAL 5 MG PREDNISONE ORAL PER 5MG TACROLIMUS ORAL PER 1 MG METHYLPREDNISOLONE ORAL PER 4 MG PREDNISOLONE ORAL PER 5 MG LYMPHOCYTE IMMUNE GLOBULIN ANTITHYMOCYTE GLOBULIN RABBIT PARENTERAL DACLIZUMAB PARENTERAL 25 MG CYCLOSPORINE ORAL 25 MG CYCLOSPORIN PARENTERAL 250 MG MYCOPHENOLATE MOFETIL ORAL 250 MG MYCOPHENOLIC ACID ORAL 180 MG SIROLIMUS ORAL 1 MG TACROLIMUS PARENTERAL 5 MG ALBUTEROL ALL FORMULATIONS INCLUDING SEPARATED ISOMERS INH SOLU ALBUTEROL ALL FORMULATIONS INCLUDING SEPARATED ISOMERS INH SOLU ARFORMOTEROL INH SOLUTION ACETYLCYSTEINE INH SOLUTION ALBUTEROL, UP TO 2.5 MG AND IPRATROPIUM BROMIDE, UP TO 0.5 MG, BUDESONIDE INH SOLUTION CROMOLYN SODIUM INH SOLUTION BUDESONIDE INH SOLUTION DORNASE ALPHA INH SOLUTION IPRATROPIUM BROMIDE INH SOLUTION ISOETHARINE HCL INH SOLUTION Page 8 of 12 February 8, 2008

11 J7649 J7658 J7659 J7668 J7669 J7674 J7682 J8501 J8510 J8515 J8520 J8521 J8530 J8540 J8560 J8565 J8600 J8610 J8650 J8700 J9000 J9001 J9010 J9015 J9017 J9020 J9025 J9027 J9031 J9035 J9040 J9041 J9045 J9050 J9055 J9060 J9062 J9065 J9070 J9080 J9090 J9091 J9092 J9093 J9094 J9095 J9096 J9097 J9098 J9100 J9110 J9120 ISOETHARINE HCL INH SOLUTION ISOPROTERENOL HCL INH SOLUTION ISOPROTERENOL HCL INH SOLUTION METAPROTERENOL SULFATE INH SOLUTION METAPROTERENOL SULFATE INH SOLUTION METHACHOLINE CHLORIDE ADMINISTERED AS INH SOLUTION THRU A NEBU TOBRAMYCIN INH SOLUTION APREPITANT ORAL 5 MG BUSULFAN; ORAL 2 MG CABERGOLINE ORAL 0.25 MG CAPECITABINE ORAL 150 MG CAPECITABINE ORAL 500 MG CYCLOPHOSPHAMIDE; ORAL 25 MG DEXAMETHASONE ORAL 0.25 MG ETOPOSIDE; ORAL 50 MG GEFITINIB ORAL 250 MG MELPHALAN; ORAL 2 MG METHOTREXATE; ORAL 2.5 MG NABILONE ORAL 1 MG TEMOZOLOMIDE ORAL 5 MG DOXORUBICIN HCL 10 MG DOXORUBICIN HCL ALL LIPID FORMULATIONS 10 MG ALEMTUZUMAB 10 MG ALDESLEUKIN PER SINGLE USE VIAL ARSENIC TRIOXIDE 1MG ASPARAGINASE UNITS INJ AZACITIDINE 1 MG INJ CLOFARABINE 1 MG BCG (INTRAVESICAL) PER INSTILLATION INJ BEVACIZUMAB 10 MG BLEOMYCIN SULFATE 15 UNITS INJ BORTEZOMIB 0.1 MG CARBOPLATIN 50 MG CARMUSTINE 100 MG INJ CETUXIMAB 10 MG CISPLATIN POWDER OR S0LUTION PER 10 MG CISPLATIN 50 MG INJ CLADRIBINE PER 1 MG CYCLOPHOSPHAMIDE 100 MG CYCLOPHOSPHAMIDE 200 MG CYCLOPHOSPHAMIDE 500 MG CYCLOPHOSPHAMIDE 1.0 GRAM CYCLOPHOSPHAMIDE 2.0 GRAM CYCLOPHOSPHAMIDE LYOPHILIZED 100 MG CYCLOPHOSPHAMIDE LYOPHILIZED 200 MG CYCLOPHOSPHAMIDE LYOPHILIZED 500 MG CYCLOPHOSPHAMIDE LYOPHILIZED 1.0 GRAM CYCLOPHOSPHAMIDE LYOPHILIZED 2.0 GRAM CYTARABINE LIPOSOME 10 MG CYTARABINE 100 MG CYTARABINE 500 MG DACTINOMYCIN 0.5 MG Page 9 of 12 February 8, 2008

12 J9130 J9140 J9150 J9151 J9160 J9165 J9170 J9175 J9178 J9181 J9182 J9185 J9190 J9200 J9201 J9202 J9206 J9208 J9209 J9211 J9212 J9213 J9214 J9215 J9216 J9217 J9218 J9219 J9225 J9226 J9230 J9245 J9250 J9260 J9261 J9263 J9264 J9265 J9266 J9268 J9270 J9280 J9290 J9291 J9293 J9300 J9303 J9305 J9310 J9320 J9340 J9350 DACARBAZINE 100 MG DACARBAZINE 200 MG DAUNORUBICIN 10 MG DAUNORUBICIN CITRATE LIPOSOMAL FORMULATION 10 MG DENILEUKIN DIFTITOX 300 MCG DIETHYLSTILBESTROL DIPHOSPHATE 250 MG DOCETAXEL 20 MG INJ ELLIOTTS' B SOLUTION 1 ML INJ EPIRUBICIN HCL 2 MG ETOPOSIDE 10 MG ETOPOSIDE 100 MG FLUDARABINE PHOSPHATE 50 MG FLUOROURACIL 500 MG FLOXURIDINE 500 MG GEMCITABINE HCL 200 MG GOSERELIN ACETATE IMPLANT PER 3.6 MG IRINOTECAN 20 MG IFOSFAMIDE 1 GM MESNA 200 MG IDARUBICIN HCL 5 MG INJ INTERFERON ALFACON-1 RECOMBINANT 1 MCG INTERFERON ALFA-2A RECOMBINANT 3 MILLION UNITS INTERFERON ALFA-2B RECOMBINANT 1 MILLION UNITS INTERFERON ALFA-N3 (HUMAN LEUKOCYTE DERIVED) IU INTERFERON GAMMA 1-B 3 MILLION UNITS LEUPROLIDE ACETATE (FOR DEPOT SUSPENSION) 7.5 MG LEUPROLIDE ACETATE PER 1 MG LEUPROLIDE ACETATE IMPLANT 65 MG HISTRELIN IMPLANT (VANTAS) 50 MG HISTRELIN IMPLANT (SUPPRELIN LA) 50 MG MECHLORETHAMINE HCL (NITROGEN MUSTARD) 10 MG INJ MELPHALAN HCL 50 MG METHOTREXATE SODIUM 5 MG METHOTREXATE SODIUM 50 MG INJ NELARABINE 50 MG INJ OXALIPLATIN 0.5 MG INJ PACLITAXEL PROTEIN-BOUND PARTICLES 1 MG PACLITAXEL 30 MG PEGASPARGASE PER SINGLE DOSE VIAL PENTOSTATIN PER 10 MG PLICAMYCIN 2.5 MG MITOMYCIN 5 MG MITOMYCIN 20 MG MITOMYCIN 40 MG INJ MITOXANTRONE HCL PER 5 MG GEMTUZUMAB OZOGAMICIN 5MG INJ PANITUMUMAB 10 MG INJ PEMETREXED 10 MG RITUXIMAB 100 MG STREPTOZOCIN 1 GM THIOTEPA 15 MG TOPOTECAN 4 MG Page 10 of 12 February 8, 2008

13 J9355 J9357 J9360 J9370 J9375 J9380 J9390 J9395 J9600 Q0144 Q0163 Q0164 Q0165 Q0166 Q0167 Q0168 Q0169 Q0170 Q0171 Q0172 Q0175 Q0176 Q0177 Q0178 Q0179 Q0180 Q2004 Q2009 Q2017 Q3025 Q3026 Q4081 Q0515 S0017 S0020 S0021 S0023 S0028 S0030 S0032 S0034 S0039 S0040 S0073 S0074 S0077 S0078 S0080 S0081 S0092 S0093 S0104 TRASTUZUMAB 10 MG VALRUBICIN INTRAVESICAL 200 MG VINBLASTINE SULFATE 1 MG VINCRISTINE SULFATE 1 MG VINCRISTINE SULFATE 2 MG VINCRISTINE SULFATE 5 MG VINORELBINE TARTRATE PER 10 MG INJ FULVESTRANT 25 MG PORFIMER SODIUM 75 MG AZITHROMYCIN DIPHENHYDRAMINE HCL 50 MG ORAL PROCHLORPERAZINE MALEATE 5 MG ORAL PROCHLORPERAZINE MALEATE 10 MG ORAL GRANISETRON HCL 1 MG ORAL DRONABINOL 2.5 MG ORAL DRONABINOL 5 MG ORAL PROMETHAZINE HCL 12.5 MG ORAL PROMETHAZINE HCL 25 MG ORAL CHLORPROMAZINE HCL 10 MG ORAL CHLORPROMAZINE HCL 25 MG ORAL PERPHENAZINE 4 MG ORAL PERPHENAZINE 8 MG ORAL HYDROXYZINE PAMOATE 25 MG ORAL HYDROXYZINE PAMOATE 50 MG ORAL ONDANSETRON HCL 8 MG ORAL DOLASETRON MESYLATE 100 MG ORAL IRRIGATION SOLUTION FOR BLADDER CALCULI INJ, FOSPHENYTOIN, 50 MG INJ, TENIPOSIDE, 50 MG INTERFERON BETA 1-A 11 MCG INJ FOR IM USE INJ, INTERFERON BETA-1A, 11 MCG INJ, EPOETIN ALFA, 100 UNITS INJ, SERMORELIN ACETATE, 1 MICROGRAM INJ AMINOCAPROIC ACID 5 GRAMS INJ BUPIVICAINE HCL 30 ML INJ CEFOPERAZONE SODIUM 1 GRAM INJ CIMETIDINE HCL 300 MG INJ FAMOTIDINE 20 MG INJ METRONIDAZOLE 500 MG INJ NAFCILLIN SODIUM 2 GRAMS INJ OFLOXACIN 400 MG INJ SULFAMETHOXAZOLE AND TRIMETHOPRIM 10 ML INJ TICARCILLIN DISODIUM & CLAVULANATE POTASSIUM 3.1 GRAMS INJ AZTREONAM 500 MG INJ CEFOTETAN DISODIUM 500 MG INJ CLINDAMYCIN PHOSPHATE 300 MG INJ FOSPHENYTOIN SODIUM 750 MG INJ PENTAMIDINE ISETHIONATE 300 MG INJ PIPERACILLIN SODIUM 500 MG INJ HYDROMORPHONE HCL 250 MG INJ MORPHINE SULFATE 500 MG ZIDOVUDINE ORAL 100 MG Page 11 of 12 February 8, 2008

14 S0108 S0137 S0142 S0143 S0145 S0146 S0155 S0156 S0157 S0162 S0164 S0171 S0172 S0176 S0178 S0179 S0182 S0189 S0190 S0191 S5010 S5011 S5012 S5013 S5014 S5550 S5551 S5552 S5553 S5565 S5566 S5570 S5571 MERCAPTOPURINE ORAL 50 MG DIDANOSINE (DDI) 25 MG COLISTIMETHATE SODIUM, INH SOLUTION AZTREONAM, INH SOLUTION INJ PEGYLATED INTERFERON ALFA-2A 180 MCG PER ML INJ PEGYLATED INTERFERON ALFA-2B 10 MCG PER 0.5 ML STERILE DILUTANT FOR EPOPROSTENOL, 50ML EXEMESTANE, 25 MG BECAPLERMIN GEL 0.01% 0.5 GM INJ EFALIZUMAB 125 MG INJ PANTOPRAZOLE SODIUM 40 MG INJ BUMETANIDE 0.5MG CHLORAMBUCIL ORAL 2MG HYDROXYUREA ORAL 500MG LOMUSTINE ORAL 10MG MEGESTROL ACETATE, ORAL, 20MG PROCARBAZINE HCL ORAL 50MG TESTOSTERONE PELLET 75MG MIFEPRISTONE ORAL 200 MG MISOPROSTOL ORAL 200 MCG 5% DEXTROSE AND 0.45% NORMAL SALINE 1000 ML 5% DEXTROSE IN LACTATED RINGER'S 1000 ML 5% DEXTROSE WITH POTASSIUM CHLORIDE 1000 ML 5% DEXTROSE/0.45% NORMAL SALINE WITH KCL AND MAG 5% DEXTROSE/0.45% NORMAL SALINE WITH KCL AND MAG INSULIN RAPID ONSET 5 UNITS INSULIN MOST RAPID ONSET (LISPRO OR ASPART); 5 UNITS INSULIN INTERMEDIATE ACTING (NPH OR LENTE); 5 UNITS INSULIN LONG ACTING; 5 UNITS INSULIN CARTRIDGE INSULIN DELIVERY DEVICE OTHER THAN PUMP; 150 UNITS INSULIN CARTRIDGE INSULIN DELIVERY DEVICE OTHER THAN PUMP; 300 UNITS INSULIN DELIVERY DEVICE DISPOSABLE PEN (INCLUDING INSULIN); 1.5 ML SIZE INSULIN DELIVERY DEVICE DISPOSABLE PEN (INCLUDING INSULIN); 3 ML SIZE Page 12 of 12 February 8, 2008

for Extended Stability Parenteral Drugs Third Edition Caryn M. Bing, R.Ph., M.S., FASHP Editor

for Extended Stability Parenteral Drugs Third Edition Caryn M. Bing, R.Ph., M.S., FASHP Editor Extended Stability for Parenteral Drugs Third Edition Editor Caryn M. Bing, R.Ph., M.S., FASHP 1 American Society of Health-System Pharmacists Bethesda, Maryland Contents Preface Acknowledgments x/ Dedication

More information

Hydration, IV Infusions, Injections and Vaccine Charge Process

Hydration, IV Infusions, Injections and Vaccine Charge Process There are a number of items to be considered when billing for the Nursing service to perform drug therapy, the charge process is divided into three specific groups of codes and processes. 1. Hydration

More information

J_Code To NDC Billing Cross Reference Guide

J_Code To NDC Billing Cross Reference Guide J_Code To Billing Cross Reference Guide J0129 Injection, abatacept, 10 mg GENERIC J0129 UN 250 MG 250 MG 25 ABATACEPT/MALTOSE J0150 6 MG Injection adenosine 6 MG GENERIC J0150 ML 3 MG/ML 3 MG ML 1 0.5

More information

HCPCS J Codes Last Updated January 2014

HCPCS J Codes Last Updated January 2014 J s Last Updated January 2014 Term J0120 INJECTION, TETRACYCLINE, UP TO 250 MG D 19860101 19970101 J0128 INJECTION, ABARELIX, 10 MG C 20050101 20050101 J0130 INJECTION ABCIXIMAB, 10 MG D 19990101 19990101

More information

Medications most likely to be seen in primary care

Medications most likely to be seen in primary care Hazardous Medicines The majority of medicines are not classed as hazardous. The only medicinal products that are automatically deemed to be hazardous are cytotoxic and cytostatic medicines. There is no

More information

Cost Differences in Cancer Care Across Settings

Cost Differences in Cancer Care Across Settings Cost Differences in Cancer Care Across Settings August 2013 THE MORAN COMPANY 1 Cost Differences in Cancer Care Across Settings In a prior memorandum, we presented evidence documenting the growing share

More information

GROUP 1 CARCINOGEN, CHEMOTHERAPY WASTE & OTHER HAZARDOUS DRUG DISPOSAL NAME APPROVAL DATE EFFECTIVE DATE REVISION RENEE MICHEL 05/01/11 0

GROUP 1 CARCINOGEN, CHEMOTHERAPY WASTE & OTHER HAZARDOUS DRUG DISPOSAL NAME APPROVAL DATE EFFECTIVE DATE REVISION RENEE MICHEL 05/01/11 0 GROUP 1 CARCINOGEN, CHEMOTHERAPY WASTE & OTHER HAZARDOUS DRUG DISPOSAL NAME APPROVAL DATE EFFECTIVE DATE REVISION RENEE MICHEL 05/01/11 0 INTRODUCTION Prior to commencing work involving carcinogens, chemotherapeutics

More information

THE HAZARDOUS WASTE (ENGLAND AND WALES) REGULATIONS 2005

THE HAZARDOUS WASTE (ENGLAND AND WALES) REGULATIONS 2005 THE HAZARDOUS WASTE (ENGLAND AND WALES) REGULATIONS 2005 Interim Guidance for the NHS Hospital Sector for England and Wales and Information for Scotland Additional paper copies may be requested by contacting:

More information

CHC Carolinas Injectable Medication Pricing

CHC Carolinas Injectable Medication Pricing C9245 INJECTION, ROMIPLOSTIM, 10 MCG $53.13 J0120 INJECTION, TETRACYCLINE, UP TO 250 MG provider submit invoice J0128 INJECTION, ABARELIX, 10 MG (Plenaxis) $80.92 J0129 INJECTION, ABATACEPT, 10 MG (ORENCIA)

More information

Drugs covered under Medicare Part B or Part D

Drugs covered under Medicare Part B or Part D LABEL_NAME GENERIC_NAME MESSAGE GEMZAR INJ 1 GM GEMCITABINE HCL FOR INJ 1 GM ALIMTA INJ 500MG PEMETREXED DISODIUM FOR IV SOLN 500 MG (BASE EQUIV) FUNGIZONE INJ 50MG AMPHOTERICIN B FOR INJ 50 MG KYTRIL

More information

MEDICAL CENTER ADMINISTRATIVE POLICY AND PROCEDURES SCOPE KFH Hospital, City Section No.

MEDICAL CENTER ADMINISTRATIVE POLICY AND PROCEDURES SCOPE KFH Hospital, City Section No. of 22 I. Purpose To establish safe medication practices for High Alert medications to maximize the safety of the medication processes associated with these medications. II. Policy. High alert medications

More information

NOTICES DEPARTMENT OF HEALTH

NOTICES DEPARTMENT OF HEALTH NOTICES DEPARTMENT OF HEALTH Approved Drugs for ALS Ambulance Services [43 Pa.B. 3060] [Saturday, June 1, 2013] Under 28 Pa. Code 1005.11 (relating to drug use, control and security), the following drugs

More information

Filtration Guidelines for the Administration of Intravenous Medications UK Pharmacy Services Revised 8/2010

Filtration Guidelines for the Administration of Intravenous Medications UK Pharmacy Services Revised 8/2010 iltration Guidelines for the Administration of Intravenous Medications UK Pharmacy Services Revised 8/2010 SUMMARY O CHANGES: Green = Added from literature (Lexi-Comp, Micromedex, pkg inserts) Yellow =

More information

NOTICES. Approved and Required Medications Lists for Emergency Medical Services Agencies and Emergency Medical Services Providers

NOTICES. Approved and Required Medications Lists for Emergency Medical Services Agencies and Emergency Medical Services Providers NOTICES Approved and Required Medications Lists for Emergency Medical Services Agencies and Emergency Medical Services Providers [45 Pa.B. 5451] [Saturday, August 29, 2015] Under 28 Pa. Code 1027.3(c)

More information

Commonwealth of Massachusetts Executive Office of Health and Human Services Office of Medicaid www.mass.gov/masshealth

Commonwealth of Massachusetts Executive Office of Health and Human Services Office of Medicaid www.mass.gov/masshealth Executive Office of Health and Human Services Office of Medicaid www.mass.gov/masshealth February 2012 TO: FROM: RE: Physicians Participating in Julian J. Harris, M.D., Medicaid Director (2012 HCPCS) This

More information

NDC HCPCS HCPCS Description NDC Description Effective Date End Date X-Over Only

NDC HCPCS HCPCS Description NDC Description Effective Date End Date X-Over Only Updated 5.5.14 NDC HCPCS HCPCS Description NDC Description Effective Date End Date X-Over Only 68152-0103-03 A9543 YTTRIUM Y-90 IBRITUMOMAB TIUXETAN ZEVALIN Y-90 VIAL 9/1/2013 12/31/2013 50419-0320-05

More information

A guide for reluctant pharmacists

A guide for reluctant pharmacists PHARMACY REIMBURSEMENT A guide for reluctant pharmacists Anne T. Jarrett, MS, RPh Anne T. Jarrett, MS, RPh Assistant Director of Pharmacy Wake Forest University Baptist Hospital Winston-Salem, North Carolina

More information

ARTICLE 4.03 AMBULANCE SERVICE* Division 1. Generally

ARTICLE 4.03 AMBULANCE SERVICE* Division 1. Generally ARTICLE 4.03 AMBULANCE SERVICE* Division 1. Generally Sec. 4.03.001 Penalty for violation Any person violating the provisions of this article shall be punished as provided in section 1.01.009. Sec. 4.03.002

More information

Drug Use Review. Edward Cox, M.D. Director Office of Antimicrobial Products

Drug Use Review. Edward Cox, M.D. Director Office of Antimicrobial Products Department of Health and Human Services Public Health Service Food and Drug Administration Center for Drug Evaluation and Research Drug Use Review Date: April 5, 2012 To: Through: Edward Cox, M.D. Director

More information

Date: November 30, 2010

Date: November 30, 2010 Department of Health and Human Services Public Health Service Food and Drug Administration Center for Drug Evaluation and Research Date: November 30, 2010 To: Through: From: Subject: Drug Name(s): Application

More information

PROJECT LIST GENERIC PRODUCTS

PROJECT LIST GENERIC PRODUCTS PROJECT LIST GENERIC PRODUCTS Acetylcysteine, Effervescent tablets 200 mg, 600 mg Alendronate sodium, Tablets 10, 70 mg Alfuzosin,Tablets 2.5mg Alfuzosin, ER Tablets 10 mg Ambroxol, Effervescent tablets

More information

PHARMACY 1000.519 Effective Date Title: 10/12 HIGH-ALERT / HIGH-RISK / HAZARDOUS / LOOK ALIKE / SOUND ALIKE MEDICATIONS. Michele Goeb-Burkett 10/12

PHARMACY 1000.519 Effective Date Title: 10/12 HIGH-ALERT / HIGH-RISK / HAZARDOUS / LOOK ALIKE / SOUND ALIKE MEDICATIONS. Michele Goeb-Burkett 10/12 XXX DAYTONA XXX _OCEANSIDE XXX HEALTH CARE PARTNERS POLICY & PROCEDURE Department: Policy Number PHARMACY 1000.519 Effective Date Title: 10/12 HIGH-ALERT / HIGH-RISK / HAZARDOUS / LOOK ALIKE / SOUND ALIKE

More information

. ก ก 1. Actifed tab/syr. Triprolidine : should be stored in tight, light-resistant Pseudoepedrine : Triprolidine (p.25) Pseudoepedrine (p.

. ก ก 1. Actifed tab/syr. Triprolidine : should be stored in tight, light-resistant Pseudoepedrine : Triprolidine (p.25) Pseudoepedrine (p. ก ก. 2553 (p.807) 3. Adrenaline inj. 1mg/ml (Epinephrine inj.) ( Druginfor. p.629) 4. Aminophylline/ Theophylline inj. (Drug infor. Ed. 11 th p.1339) 5. Amlodipine + HCTZ (Moduretic). ก ก 1. Actifed tab/syr.

More information

MEDICARE PART B CHEMOTHERAPY ADMINISTRATION: PAYMENT AND POLICY

MEDICARE PART B CHEMOTHERAPY ADMINISTRATION: PAYMENT AND POLICY Department of Health and Human Services OFFICE OF INSPECTOR GENERAL MEDICARE PART B CHEMOTHERAPY ADMINISTRATION: PAYMENT AND POLICY Daniel R. Levinson Inspector General June 2009 OEI-09-08-00190 Office

More information

Authorized by the U.S. District Court for the District of Massachusetts

Authorized by the U.S. District Court for the District of Massachusetts Authorized by the U.S. District Court for the District of Massachusetts If you made a Cash Payment or Percentage Co-Payment for Certain Drugs, from January 1, 1991 to March 1, 2008, you may be able to

More information

MEDICAL COLLEGE & HOSPITAL IN DOOR ESSENTIAL DRUG LIST

MEDICAL COLLEGE & HOSPITAL IN DOOR ESSENTIAL DRUG LIST ANNEXURE - D MEDICAL COLLEGE & HOSPITAL IN DOOR ESSENTIAL DRUG LIST Bihar EDL 1. Anaesthetics 1.1 Local Anaesthetics Bupivacaine Injection Plain-0.5% (5mg/ml) Hydrochloride Heavy-0.5% + 80mg/ml Dextrose

More information

Objectives PREVENTION AND TREATMENT OF CINV & VTE IN ONCOLOGY PATIENTS. Case 1. Case 1. Case 2 2/1/2015

Objectives PREVENTION AND TREATMENT OF CINV & VTE IN ONCOLOGY PATIENTS. Case 1. Case 1. Case 2 2/1/2015 Objectives PREVENTION AND TREATMENT OF CINV & VTE IN ONCOLOGY PATIENTS Jennifer Gallanger, Pharm.D. Jennifer Kubert, Pharm.D. Pharmacy Practice Residents Providence Alaska Medical Center Discuss the pathophysiology

More information

MASCC/ESMO Antiemetic Guideline 2013

MASCC/ESMO Antiemetic Guideline 2013 MASCC/ESMO Antiemetic Guideline 2013 Multinational Association of Supportive Care in Cancer Organizing and Overall Meeting Chairs: Richard J. Gralla, MD Fausto Roila, MD Maurizio Tonato, MD Jørn Herrstedt,

More information

Directory of Generic Medications Eligible for Rx Savings Program Flat Fees

Directory of Generic Medications Eligible for Rx Savings Program Flat Fees Directory of Generic Medications Eligible for Rx Savings Program Flat Fees CONNECTICUT VERSION If you re already enrolled in the FREE* Rx Savings Program, use this guide to find your best choices. And,

More information

LTC Pharmacy Setting B/D Coverage. Because most LTC facilities are not considered a beneficiary s home 3

LTC Pharmacy Setting B/D Coverage. Because most LTC facilities are not considered a beneficiary s home 3 Medicare Parts Issues This table provides a reference guide for the most frequent B/D coverage determination scenarios facing Part D plans and Part D pharmacy providers. It does not address all potential.

More information

Emergency Medications Approved for Use at VAPAHCS

Emergency Medications Approved for Use at VAPAHCS Table 1: Medications (PAD GM&S) Emergency Medications Approved for Use at VAPAHCS PAD GM&S (See HCSM 11-12-35 Attachment A CPR Committee Atropine 1mg/10ml syringe X 3 Normal saline 1000ml bag X 2 Sodium

More information

Guidelines for the Management of. Nausea and Vomiting in Cancer Patients

Guidelines for the Management of. Nausea and Vomiting in Cancer Patients Guidelines for the Management of Nausea and Vomiting in Cancer Patients Guidelines for the Management of Nausea and Vomiting in Cancer Patients Management of chemotherapy-induced nausea and vomiting includes

More information

Home Delivery Prescription Program Drug List

Home Delivery Prescription Program Drug List Home Delivery Prescription Program Drug List Low-cost prescriptions, right in your mailbox. Now you can have your generic prescriptions mailed right to your home, no matter where you live. Because we think

More information

2015/2016 Schedule of Home Medical Services and Fees for Approved Agencies

2015/2016 Schedule of Home Medical Services and Fees for Approved Agencies 2015/2016 Schedule of Home Medical Services and Fees for Approved Agencies Legislative Authority: Health Insurance Act (Standard Hospital Benefit) Regulations 1971- Section 3(xv) This schedule lists the

More information

Appendix 4: Guidelines for Prescribing and Administering Drugs:

Appendix 4: Guidelines for Prescribing and Administering Drugs: Appendix 4: Guidelines for Prescribing and Administering Drugs: A midwife may prescribe and administer the following substances in accordance with the guidelines approved by the Board. This list indicates

More information

Meridian Health Plan Drugs Covered under the Medical Benefit* Updated 09/2015 PA Required

Meridian Health Plan Drugs Covered under the Medical Benefit* Updated 09/2015 PA Required J0129 J0130 J0586 J9264 J3262 J0800 J0135 C9287 J0178 J0180 J9015 J1931 J0215 J9010 J0205 J0220 J9305 J2469 J0256 J0207 J7308 J0285 J0288 J0287 J0289 Abatacept Injection Abciximab AbobotulinumtoxinA Abraxane

More information

PREFERRED GENERIC DRUG LIST

PREFERRED GENERIC DRUG LIST These discount programs are NOT health insurance policies and are not intended as a substitute for insurance. The programs do not qualify as a minimum creditable coverage under Massachusetts law or where

More information

Retail Prescription Program Drug List

Retail Prescription Program Drug List Retail Prescription Program Drug List Price Matters New Men s Health Category Convenience Free Home Delivery Our 4 prescriptions have saved our customers over 3 billion The program is available to everyone,

More information

Liofilchem - Antibiotic Disk Interpretative Criteria and Quality Control - F14013 - Rev.7 / 20.02.2013

Liofilchem - Antibiotic Disk Interpretative Criteria and Quality Control - F14013 - Rev.7 / 20.02.2013 Liofilchem Antibiotic Disk Interpretative Criteria and Quality Control F0 Rev.7 /.02. Amikacin AK Amoxicillin + Clavulanic acid AUG (+) ATCC 352 Coagulasenegative staphylococci Amoxicillin + Clavulanic

More information

Waste Management Policy

Waste Management Policy Sharepoint Location Non-clinical Policies and Guidelines Sharepoint Index Directory 3.0 Corporate Sub Area 3.2 Trustwide Management Key words (for search purposes) Waste, Hazardous, Sharps, Household Central

More information

TOTAL PARENTERAL NUTRITION SOLUTIONS

TOTAL PARENTERAL NUTRITION SOLUTIONS TOTAL PARENTERAL NUTRITION SOLUTIONS TOTAL PARENTERAL NUTRITION SOLUTIONS Issued 6/98 NOTE: Because of the complexity of these solutions, the customary format of the Guide cannot be used. The double entry

More information

$10.00 PRESCRIPTION PROGRAM DETAILS

$10.00 PRESCRIPTION PROGRAM DETAILS $10.00 PRESCRIPTION PROGRAM DETAILS 1. The $10.00 program applies only to certain generic drugs at commonly prescribed 90 day usage dosages. (See list). 2. The Program may change without notification and

More information

Outpatient Billing/Coding: A Focus on Missed Reimbursement & Quality of Reported Data

Outpatient Billing/Coding: A Focus on Missed Reimbursement & Quality of Reported Data Outpatient Billing/Coding: A Focus on Missed Reimbursement & Quality of Reported Data 438 e wilson bridge road, suite 200 worthington, oh 43085-2382 888-779-5663 www.cleverleyassociates.com 1 All US Average

More information

Look-Alike Drug Names with Recommended Tall Man Letters

Look-Alike Drug Names with Recommended Tall Man Letters FDA and ISMP Lists of Look-Alike Drug Names with Recommended Tall Man Letters Since 2008, ISMP has maintained a list of drug name pairs and trios with recommended, bolded tall man (uppercase) letters to

More information

Drug Dosage Practice Problems

Drug Dosage Practice Problems Drug Dosage Practice Problems Topics covered: Metric Conversions ---------------------------------------------------------------- pg 2 General Conversions --------------------------------------------------------------

More information

NIOSH List of Antineoplastic and Other Hazardous Drugs in Healthcare Settings 2010

NIOSH List of Antineoplastic and Other Hazardous Drugs in Healthcare Settings 2010 NIOSH List of Antineoplastic and Other Hazardous Drugs in Healthcare Settings 2010 DEPARTMENT OF HEALTH AND HUMAN SERVICES Centers for Disease Control and Prevention National Institute for Occupational

More information

MOH Policy for dispensing NEOPLASTIC DISEASES DRUGS

MOH Policy for dispensing NEOPLASTIC DISEASES DRUGS MOH Policy for dispensing NEOPLASTIC DISEASES DRUGS All prescriptions for antineoplastic drugs must be accompanied by the MOH special form. All the attachments mentioned on this form shall be submitted

More information

602 Nonpayable CPT Codes

602 Nonpayable CPT Codes 6-1 601 Introduction providers must refer to the American Medical Association s Current Procedural Terminology (CPT) 2015 code book for the descriptions for the service codes when billing for services

More information

SOUTH CENTRAL AMBULANCE SERVICE NHS FOUNDATION TRUST CORPORATE POLICY & PROCEDURE. No EPP20 WASTE MANAGEMENT. November 2015

SOUTH CENTRAL AMBULANCE SERVICE NHS FOUNDATION TRUST CORPORATE POLICY & PROCEDURE. No EPP20 WASTE MANAGEMENT. November 2015 SOUTH CENTRAL AMBULANCE SERVICE NHS FOUNDATION TRUST CORPORATE POLICY & PROCEDURE No EPP20 WASTE MANAGEMENT November 2015 DOCUMENT INFORMATION Author: Mike Kerrigan Head of Estates Consultation & Approval:

More information

DRUGS BILLED UNDER MISCELLANEOUS CODES J3490, J3590, J9999 OR C9399 COVERAGE INFORMATION

DRUGS BILLED UNDER MISCELLANEOUS CODES J3490, J3590, J9999 OR C9399 COVERAGE INFORMATION ACTEMRA (toclizumab) 10/21/13 ADASUVE (loxapine aerosol powder breath activated) 01/24/14 ADDAMEL N INJ (Trace Min (CR-CU-F-FE-I-MN-MO-SE-ZN) INJ) 05/20/13 ADYNOVATE (Antihemophilic Factor Recomb Pegylated

More information

New York Methodist Hospital Drug Protocols

New York Methodist Hospital Drug Protocols New York Methodist Hospital Drug Protocols Contributed by Administrator Monday, 05 October 2009 Last Updated Friday, 27 May 2016 NYM Intranet New York Methodist Hospital Drug Protocols are approved by

More information

Palliative Care Drug Plan (Plan P) Formulary List of drugs PharmaCare covers

Palliative Care Drug Plan (Plan P) Formulary List of drugs PharmaCare covers Palliative Care Drug Plan (Plan P) Formulary List of drugs PharmaCare covers Important Notes: Last Updated: May 11, 2015 Pharmacists must submit a claim on PharmaNet at the time of purchase to enable coverage.

More information

$4, 30-day $10, 90-day

$4, 30-day $10, 90-day $4 Prescriptions - Choose from hundreds of generic drugs and over the counter medications. Free Home Delivery Mailed right to your home Free shipping Prescription Program includes up to a 30-day supply

More information

FORMULARY. (List of Covered Drugs) Molina Dual Options Medicare-Medicaid Plan

FORMULARY. (List of Covered Drugs) Molina Dual Options Medicare-Medicaid Plan FORMULARY (List of Covered Drugs) 2015 Molina Dual Options Medicare-Medicaid Plan Version 14 UPDATED: 11/2015 Member Services (877) 901-8181, TTY/TDD 711 Monday - Friday, 8 a.m. - 8 p.m. local time H8046_15_16003_0002_MMPILRx

More information

Dosing information in renal impairment

Dosing information in renal impairment No. Drug name Usual dose Adjustment for Renal failure estimated CrCl (ml/min) Aminoglycoside antibiotics 1 Amikacin 2 Gentamicin 7.5 mg /kg q 12 hr > 50-90 7.5 mg/kg q 12 hr 10-50 7.5 mg/kg q 24 hr < 10

More information

Drug Classifications. Cholinergic (parasympathetic) drugs Ex. Acetylcholine, bethanecol, neostigmine, guanidine

Drug Classifications. Cholinergic (parasympathetic) drugs Ex. Acetylcholine, bethanecol, neostigmine, guanidine Drug Classifications I. Autonomic nervous system drugs Cholinergic (parasympathetic) drugs Ex. Acetylcholine, bethanecol, neostigmine, guanidine Cholinergic blocking drugs Ex. Atropine, scopolamine Adrenergic

More information

PREPARATIONS: Adrenaline 1mg in 1ml (1:1000) Adrenaline 100micrograms in 1ml (1:10,000)

PREPARATIONS: Adrenaline 1mg in 1ml (1:1000) Adrenaline 100micrograms in 1ml (1:10,000) ADRENALINE Acute hypotension Via a CENTRAL venous line Initially 100-300 nanograms/kg/minute 0.1-0.3 microgram/kg/minute adjusted according to response up to a maximum of 1.5 micrograms/kg/minute. Increase

More information

BIOTECHNOLOGY SYNTHESIS CORTICOSTEROIDS FRANCOPIA PROSTAGLANDINS PRODUCT LIST JUNE 2013

BIOTECHNOLOGY SYNTHESIS CORTICOSTEROIDS FRANCOPIA PROSTAGLANDINS PRODUCT LIST JUNE 2013 BIOTECHNOLOGY SYNTHESIS CORTICOSTEROIDS FRANCOPIA PROSTAGLANDINS PRODUCT LIST JUNE 2013 Validity of this document: December 2013 API Name Business Unit Page API Name Business Unit Page Acebutolol hydrochloride

More information

Synagis (Palivizumab)

Synagis (Palivizumab) Texas Prior Authorization Program Clinical Edit Criteria Drug/Drug Class Clinical Edit Information Included in this Document Drugs requiring prior authorization: the list of drugs requiring prior authorization

More information

Medication Calculation Practice Problems

Medication Calculation Practice Problems 1 Medication Calculation Practice Problems Dosage Calculation 1. The order is for 60 mg of furosemide (Lasix) po daily. Available to the nurse is Lasix 40 mg/tablet. The nurse would administer how many

More information

Oncologic drug Exposure Risks and Prevention Guidelines 19 June 2014

Oncologic drug Exposure Risks and Prevention Guidelines 19 June 2014 Oncologic drug Exposure Risks and Prevention Guidelines 19 June 2014 ส งค กคามซ งอาจเป นอ นตรายต อส ขภาพ HAZARD? HAZARD ส งค กคามซ งอาจเป นอ นตรายต อส ขภาพ ENCLOSURE Substitution ส งค กคามซ งอาจเป นอ นตรายต

More information

MEDICATION MANUAL Policy & Procedure

MEDICATION MANUAL Policy & Procedure MEDICATION MANUAL Policy & Procedure TITLE: High Alert Medication NUMBER: MM 50-010 Effective Date: September 13, 2013 Page 1 of 6 Applies To: Holders of Medication Manual This policy is applicable to

More information

Calculations Practice Problems

Calculations Practice Problems Calculations Practice Problems Note: A variety of types of problems are provided for practice. Not all situations will be encountered in all states, depending on state limitations to LPN/LVN practice.

More information

Asthma, COPD and Diabetes Preferred Drug List Medications

Asthma, COPD and Diabetes Preferred Drug List Medications GPI Name Dexamethasone Tab 0.5 MG Dexamethasone Tab 0.75 MG Dexamethasone Tab 1 MG Dexamethasone Tab 1.5 MG Dexamethasone Tab 2 MG Dexamethasone Tab 4 MG Dexamethasone Tab 6 MG Dexamethasone Elixir 0.5

More information

I.V. ADMINISTRATION GUIDELINES All IV meds must be administered by IV pump. Diluent Amount Over (min.) NO D5W 200mL. 500ml. 1000ml.

I.V. ADMINISTRATION GUIDELINES All IV meds must be administered by IV pump. Diluent Amount Over (min.) NO D5W 200mL. 500ml. 1000ml. I.V. ADMINISTRATION GUIDELINES All IV meds must be administered by IV pump Medication Dose Push Acetadote Patients greater than 40 kg Loading Dose: Dose 2: Dose 3: Please use the Online calculator: http://aceta

More information

Examples of Compounded and Difficult to Find Preparations Requested from Ophthalmologists for their Patients (List not complete)

Examples of Compounded and Difficult to Find Preparations Requested from Ophthalmologists for their Patients (List not complete) Examples of Compounded and Difficult to Find Preparations Requested from Ophthalmologists for their Patients (List not complete) Acanthamoeba (various) Ophthalmic Solution Acetazolamide-PF 1% Ophthalmic

More information

Emergency Medical Items Catalogue 2002. Code Description Ind. price Ship. weight Ship. Vol.

Emergency Medical Items Catalogue 2002. Code Description Ind. price Ship. weight Ship. Vol. Injectable drugs DINJACSA5V ACETYLSALICYLAT LYSINE, 0.9 g (aspirin 0.5 g), powder vial Injectable analgesic, antipyretic, anti inflammatory. Not in the WHO Essential Medicines list 2002. Action is rapid,

More information

In this issue Page. anthem.com. Important phone numbers. May 2012

In this issue Page. anthem.com. Important phone numbers. May 2012 May 2012 In this issue Page Announcement Anthem rolls out Quality-In-Sights Program in Virginia 3 Use Provider Online Interactive Tool to view information regarding Anthem Quality-In-Sights 4 Coverage

More information

Special Resource. Drugs to be Used with a Filter for Preparation and/or Administration

Special Resource. Drugs to be Used with a Filter for Preparation and/or Administration Hospital Pharmacy Volume 42, Number 4, pp 378 382 2007 Wolters Kluwer Health, Inc. Special Resource Drugs to be Used with a Filter for Preparation and/or Administration Prepared by: Wolters Kluwer Health/Facts

More information

INTRAVENOUS DRUG QUICKGUIDE

INTRAVENOUS DRUG QUICKGUIDE INTRAVENOUS DRUG QUICKGUIDE GENERAL NOTES IMPORTANT THIS GUIDE IS AN AIDE MEMOIRE ONLY, AND SHOULD NOT REPLACE YOUR PROFESSIONAL REQUIREMENT TO USE MANUFACTUER S LICENSED INFORMATION TO INFORM YOUR PREPARATION

More information

RECONSTITUTING MEDICATIONS: HOW TO FLUFF UP MEDICATIONS

RECONSTITUTING MEDICATIONS: HOW TO FLUFF UP MEDICATIONS RECONSTITUTING MEDICATIONS: HOW TO FLUFF UP MEDICATIONS After the completion of this module you will be able to: Define medication reconstitution. Read a medication label. Reconstitute a medication. Calculate

More information

Generic Pharmacy Discount

Generic Pharmacy Discount Generic Pharmacy Discount 83 Park Place Blvd Suite 101 Clearwater, FL 33759 Fourth Quarter 2014 727.461.6044 800.314.0088 Pharmacies Generic Discount Program Information Enclosed information provided

More information

APC Status Description 00001 S LEVEL I PHOTOCHEMOTHERAPY 00002 T LEVEL I FINE NEEDLE BIOPSY/ASPIRATION 00003 T BONE MARROW BIOPSY/ASPIRATION 00004 T

APC Status Description 00001 S LEVEL I PHOTOCHEMOTHERAPY 00002 T LEVEL I FINE NEEDLE BIOPSY/ASPIRATION 00003 T BONE MARROW BIOPSY/ASPIRATION 00004 T APC Status Description 00001 S LEVEL I PHOTOCHEMOTHERAPY 00002 T LEVEL I FINE NEEDLE BIOPSY/ASPIRATION 00003 T BONE MARROW BIOPSY/ASPIRATION 00004 T LEVEL I NEEDLE BIOPSY/ ASPIRATION EXCEPT BONE MARROW

More information

DRUG CALCULATIONS FOR REGISTERED NURSES ADULT SERVICES

DRUG CALCULATIONS FOR REGISTERED NURSES ADULT SERVICES Serving the people of north east Essex DRUG CALCULATIONS FOR REGISTERED NURSES ADULT SERVICES A Programmed Approach - It is essential you read this pack & practice the questions prior to your drug calculation

More information

Union EMS Local Formulary July 18, 2014

Union EMS Local Formulary July 18, 2014 July 18, 2014 Forward The intent of the Union EMS Local Formulary is to provide guidance during the implementation and use of the 2012 NCCEP Protocols, Policies and Procedures to the ALS and BLS Professionals

More information

Coverage and Pricing. of Drugs That Can Be Covered Under. Part B and Part D

Coverage and Pricing. of Drugs That Can Be Covered Under. Part B and Part D Coverage and Pricing Elizabeth Hargrave NORC at the University of Chicago Jack Hoadley of Drugs That Can Be Covered Under Part B and Part D Jennifer Thompson Georgetown University MedPAC A study conducted

More information

OfficeMate 11.0 Enhancements

OfficeMate 11.0 Enhancements In this document: Eyefinity EHR Integration, 1 Patient Center, 2 Patient Demographic, 2 Rx Order Windows, 3 Products and Services, 4 For more detailed information on how to use the new features in OfficeMate

More information

4. Read articles about various classes of drugs, e.g., corticosteroids, antihistamines, anticoagulants, antibiotics, etc. (See unit bibliographies.

4. Read articles about various classes of drugs, e.g., corticosteroids, antihistamines, anticoagulants, antibiotics, etc. (See unit bibliographies. PHARMACOLOGY CONTENT Tips for Studying 1. Use your pharmacology textbook to study for this exam. Use a nursing drug book only to add to or clarify information. Read the whole chapter about each classification.

More information

AETNA BETTER HEALTH OF OHIO a MyCare Ohio plan

AETNA BETTER HEALTH OF OHIO a MyCare Ohio plan AETNA BETTER HEALTH OF OHIO a MyCare Ohio plan 2015 List of Covered Drugs/Formulary Aetna Better Health of Ohio, a MyCare Ohio plan (Medicare-Medicaid Plan) is a health plan that contracts with Medicare

More information

LESSON ASSIGNMENT. After completing this lesson, you should be able to: 2-1. Compute medication dosages by the ratio and proportion method.

LESSON ASSIGNMENT. After completing this lesson, you should be able to: 2-1. Compute medication dosages by the ratio and proportion method. LESSON ASSIGNMENT LESSON 2 Pharmacology TEXT ASSIGNMENT Paragraphs 2-1 through 2-34. LESSON OBJECTIVES After completing this lesson, you should be able to: 2-1. Compute medication dosages by the ratio

More information

Review of the List of High-Cost Medicines used by the Dominican Republic s Protected Diseases Program and Planning of Purchases for 2015

Review of the List of High-Cost Medicines used by the Dominican Republic s Protected Diseases Program and Planning of Purchases for 2015 Review of the List of High-Cost Medicines used by the Dominican Republic s Protected Diseases Program and Planning of Purchases for 2015 July 2014 Review of the List of High-Cost Medicines Used by the

More information

Intravenous Push (IVP) Drug List Approved for RN Administration

Intravenous Push (IVP) Drug List Approved for RN Administration Acute Care 1111Page Floor Nurses 1 of 8 Guide: Bumetanide (Bumex) - Diuretic/Acute Pulmonary Edema, CHF, and Renal disease 0.5-2 mg over 1-2 RATE 10 mg/day 0.25 mg/ml 2 mg over 2 Pain at injection Site

More information

North Carolina Medical Board Approved Medications for Credentialed EMS Personnel

North Carolina Medical Board Approved Medications for Credentialed EMS Personnel North Carolina Medical Board Approved Medications for Credentialed EMS Personnel EMS personnel at any level who administer medications must do so within an EMS system that provides medical oversight. Personnel

More information

Health (Drugs and Poisons) Regulation 1996. Drug Therapy Protocol Rural and Isolated Practice Area Endorsed Nurse

Health (Drugs and Poisons) Regulation 1996. Drug Therapy Protocol Rural and Isolated Practice Area Endorsed Nurse Health (Drugs and Poisons) Regulation 1996 Drug Therapy Protocol Rural and Isolated Practice Area Endorsed Nurse Health Protection Unit Medicines Regulation and Quality PO Box 21 Fortitude Valley BC QLD

More information

Pharmacy Savings Program

Pharmacy Savings Program Pharmacy Savings Program SELECT GENERICS DRUG LIST The Pharmacy Savings Program provides you with savings on select generic medications included on this list. The prices for these select generic medications

More information

Dosage Calculations INTRODUCTION. L earning Objectives CHAPTER

Dosage Calculations INTRODUCTION. L earning Objectives CHAPTER CHAPTER 5 Dosage Calculations L earning Objectives After completing this chapter, you should be able to: Solve one-step pharmaceutical dosage calculations. Set up a series of ratios and proportions to

More information

Basic Medication Administration Exam RN (BMAE-RN) Study Guide

Basic Medication Administration Exam RN (BMAE-RN) Study Guide Basic Medication Administration Exam RN (BMAE-RN) Study Guide Review correct procedure and precautions for the following routes of administration: Ear drops Enteral feeding tube Eye drops IM, subcut injections

More information

Acetylcysteine Inhalation Solution

Acetylcysteine Inhalation Solution Drug Shortage information Action Plan delays and another manufacturer voluntarily suspending production. Hospira has a limited supply available and other manufacturers are unable to estimate a release

More information

Basic Medication Administration Exam LPN/LVN (BMAE-LPN/LVN) Study Guide

Basic Medication Administration Exam LPN/LVN (BMAE-LPN/LVN) Study Guide Basic Medication Administration Exam LPN/LVN (BMAE-LPN/LVN) Study Guide Review correct procedure and precautions for the following routes of administration: Ear drops Enteral feeding tube Eye drops IM,

More information

INSTITUTIONAL POLICY AND PROCEDURE (IPP) Department: Manual: Section: EFFECTIVE DATE REVIEW DUE REPLACES NUMBER NO. OF PAGES

INSTITUTIONAL POLICY AND PROCEDURE (IPP) Department: Manual: Section: EFFECTIVE DATE REVIEW DUE REPLACES NUMBER NO. OF PAGES HOSPITAL NAME INSTITUTIONAL POLICY AND PROCEDURE (IPP) Department: Manual: Section: TITLE/DESCRIPTION POLICY NUMBER HIGH RISK MEDICATIONS EFFECTIVE DATE REVIEW DUE REPLACES NUMBER NO. OF PAGES APPROVED

More information

Product Catalogue 2015 Clinical and Industrial Microbiology

Product Catalogue 2015 Clinical and Industrial Microbiology Product Catalogue 201 Antibiotic discs in cartridge µg CLSI 1,2 EUCAST 3,4 BSAC Packaging * Amikacin AK x0 Discs 9004 Amoxicillin AML 2 x0 Discs 911 Amoxicillin AML x0 Discs 9133 Amoxicillin AML 2 x0 Discs

More information

NEW SCHEDULE H1 INSERTED IN DRUGS AND COSMETICS RULES :

NEW SCHEDULE H1 INSERTED IN DRUGS AND COSMETICS RULES : LOCOST 85, GIDC Estate, Por-Ramangamdi, N.H.8, Dist. Vadodara - 391 243 Gujarat, India. Tel. No.: (91-265) 2830009 Fax No.: (P.P.) 2831446 E-mail: locost@sify.com Website: www.locostindia.com A Public

More information

Preventing and Treating Nausea and Vomiting Caused by Cancer Treatment

Preventing and Treating Nausea and Vomiting Caused by Cancer Treatment A Patient s Guide Preventing and Treating Nausea and Vomiting Caused by Cancer Treatment Recommendations of the American Society of Clinical Oncology The American Society of Clinical Oncology (ASCO) is

More information

The Impact of IV Automation on Improving Safety, Efficiency and Workflow

The Impact of IV Automation on Improving Safety, Efficiency and Workflow The Impact of IV Automation on Improving Safety, Efficiency and Workflow David Webster, RPh, MSBA University of Rochester Medical Center Department of Pharmacy Associate Director of Operations Director,

More information

ASWCS Policy for the Treatment of Extravasation Injury

ASWCS Policy for the Treatment of Extravasation Injury ASWCS Policy for the Treatment of Extravasation Injury Extravasation of Cytotoxic Drugs Introduction 1. The purpose of this policy is to inform practitioners of their responsibilities in relation to preventing

More information

ANTIMICROBIAL AGENT CLASSES AND SUBCLASSES

ANTIMICROBIAL AGENT CLASSES AND SUBCLASSES ANTIMICROBIAL AGENT CLASSES AND SUBCLASSES FOR USE WITH CLSI DOCUMENTS M2 AND M7 Beta-lactams: penicillins e penicillin a penicillin beta-lactam/beta-lactamase inhibitor combinations aminopenicillin a

More information

An introduction to High Risk Medications

An introduction to High Risk Medications An introduction to High Risk Medications Une politique sure des médicaments : déjà deux approches 25 octobre 2013 Danguy Christine Hôpital A. Vésale An introduction to High Risk Medications 1. High Risk

More information

PREFERRED GENERIC DRUG LIST

PREFERRED GENERIC DRUG LIST ALLERGIES & COLD AND FLU Preferred generic drugs MARCH 2013 supply* for $5 supply* for $10 and $15 * The day supply is based upon the average dispensing patterns for the specific drug and strength. 90-

More information

Local Coverage Article: Self-Administered Drug Exclusion List (A51866)

Local Coverage Article: Self-Administered Drug Exclusion List (A51866) Local Coverage Article: Self-Administered Drug Exclusion List (A51866) Contractor Information Contractor Name Novitas Solutions, Inc. Article Information General Information Article ID A51866 General Article

More information

SPECIAL AUTHORIZATION GUIDELINES

SPECIAL AUTHORIZATION GUIDELINES 91B ALBERTA DRUG BENEFIT LIST SPECIAL AUTHORIZATION GUIDELINES 37BSpecial Authorization Policy 90BDrug Products Eligible for Consideration by Special Authorization Drug Products may be considered for coverage

More information